Almost 70% of the total NPM1 mutations are type A, while 11% are type B. Type A mutations are very often observed with concomitant DNMT3A mutations, which are responsible for worse prognoses in type A and type D NPM1-mutated AML [15]. Here, NPM1 is linked to acute myeloid leukemia.